SCHEMBL17344111

SCHEMBL17344111

CCC(=O)NC(CC)S(=O)(=O)O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.43
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 2/20 0.32
LMNA P02545 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
MAPK1 P28482 1/20 0.31
CCR6 P51684 1/20 0.31
MCL1 Q07820 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31
POLB P06746 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28044631 0.83 CYP2C9 (0.41) CYP2C9MEN1KMT2AATMLMNA
SCHEMBL346041 0.80 KDM4E (0.34) KDM4EALDH1A1MAPTMAPK1CA12
SCHEMBL2513923 0.80 CYP2D6 (0.34) MEN1KMT2AALDH1A1PKMCA12
SCHEMBL10951510 0.77 FAAH (0.58) MEN1KMT2AALDH1A1MAPK1
SCHEMBL7026251 0.77 CNR2 (0.34) MEN1KMT2AALDH1A1CA12CA1
SCHEMBL9333253 0.76 CYP2C9 (0.45) CYP2C9MEN1KMT2AATMLMNA
SCHEMBL28077512 0.75 TSHR (0.48) CYP2C9ALDH1A1MAPK1
SCHEMBL34026 0.75 TSHR (0.48) CYP2C9ALDH1A1MAPK1
SCHEMBL11422053 0.74
SCHEMBL4613630 0.74 TSHR (0.47) CYP2C9ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150361116-A1 NOVEL WATER-SOLUBLE COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES CISBIO BIOASSAYS (FR) 2015-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361116-A1 NOVEL WATER-SOLUBLE COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES RCC1, CLIC1, RCC2 CYP2C9 3016/4885MEN1 123/4885KMT2A 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.